🇺🇸 FDA
Pipeline program

Cytokine-induced killer cells

Melanoma001

Phase 2 mab active

Quick answer

Cytokine-induced killer cells for Melanoma is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Melanoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials